Q2 2024 Altimmune Inc Earnings Call Transcript

Author's Avatar
Aug 08, 2024

Aug 08, 2024 / 12:30PM GMT
Operator

Good day, ladies and gentlemen, and welcome to Altimmune, Inc. second quarter 2024 financial results conference call. (Operator Instructions) As a reminder, this call is being recorded. I would now like to introduce your host for today's conference call, Lee Roth of Burns McClellan, Investor Relations advisers to Altimmune. Lee, you may begin.

Lee Roth - Burns McClellan - Investor Relations

Thanks, Gigi. Good morning, everyone. Thank you for participating on the Altimmune second quarter 2024 financial results and business update conference call. Members of the Altimmune team joining me today are Vipin Garg, our Chief Executive Officer; Scott Harris, our Chief Medical Officer; Ray Jordt, our Chief Business Officer; Andrew Shutterly, our acting Chief Financial Officer; and Scot Roberts, our Chief Scientific Officer.

Following prepared remarks from Vipin, Scott Harris and Andrew, we'll hold a Q&A session. As a reminder, our press release with our Q2 2024 financial results was issued this morning and can be found on the IR section of the company's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot